Here are three points:
1. EndoChoice has declined 60.1 percent since September 18, 2015 and is trending downward.
2. The company’s stock has underperformed the S&P500 by 66.73 percent.
3. The company has a market cap of $147.51 million.
More articles on GI/endoscopy:
Dr. Asad Rafiq joins Blessing Physician Services: 3 notes
Medtronic issues voluntary recall Capnostream monitor battery pack: 4 points
Dr. Steven Ayres designated AGA fellow — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
